Marimed (MRMD) Revenue (2011 - 2026)

Marimed (MRMD) has 16 years of Revenue data on file, last reported at $39.5 million in Q1 2026.

• On a quarterly basis, Revenue rose 4.16% year-over-year to $39.5 million in Q1 2026; TTM through Mar 2026 was $161.5 million, a 2.29% increase from a year earlier, with the FY2025 full-year figure at $159.8 million, up 1.34% from the prior year.
• Revenue for Q1 2026 stood at $39.5 million, down from $41.6 million in the prior quarter.
• Over the last five years, Revenue for MRMD reached as high as $41.6 million in Q4 2025 and fell as low as $31.3 million in Q1 2022.
• Historically, Revenue has averaged $37.6 million across 5 years, with a median of $38.8 million in 2023.
• Across the five-year window, Revenue climbed 26.94% in 2022 and dropped 2.05% in 2025, its largest moves.
• Year by year, Revenue stood at $35.8 million in 2022, then grew by 8.57% to $38.9 million in 2023, then advanced by 0.13% to $38.9 million in 2024, then rose by 6.93% to $41.6 million in 2025, then dropped by 5.21% to $39.5 million in 2026.
• Per Business Quant data, the three most recent Revenue figures were $39.5 million in Q1 2026, $41.6 million in Q4 2025, and $40.8 million in Q3 2025.